Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Entain Jumps 27% After MGM Takeover Tilt

Mon, 04th Jan 2021 08:37

(Alliance News) - Stock prices in Europe opened higher on Monday, despite the threat of more Covid-19 lockdowns, with investors instead focusing on the promise of vaccine rollouts.

A new national lockdown looks likely to be imposed across England as the UK government was accused by Labour of letting coronavirus "get out of control". As events developed rapidly, the Daily Mail reported the government's key "Covid-O" committee that oversees restrictions was expected to meet on Monday to decide changes to the coronavirus regime.

The newspaper quoted a UK government source as saying ministers were looking at putting even more areas of England into the toughest Tier 4, which already covers a total of 44 million people – or 78% of the population – after changes which came into effect on Thursday.

The FTSE 100 index was up 127.81 points, or 2.9%, at 6,588.33 early Monday. The blue-chip stock measure was up sharply despite a rising pound, which reduces the sterling value of the overseas earnings of the index's constituents.

The mid-cap FTSE 250 index was up 181.84 points, or 0.9%, at 20,670.14. The AIM All-Share index rose 0.5% to 1,162.78.

The Cboe UK 100 index was up 1.8% at 655.49. The Cboe 250 was up 0.9% at 18143.28, and the Cboe Small Companies was up 0.2% 11753.37.

In Paris, the CAC 40 was up 1.5%, while Frankfurt's DAX 30 climbed 1.1%.

"Chances are that 2021 could turn into an exceptionally good year for the global economy. After a dreadful 2020, a calmer US trade policy, vaccines that work, and the end of the most serious Brexit uncertainty underpin a positive economic outlook for 2021 despite the horrific toll which the Covid-19 pandemic will continue to take across much of the world in the next few months," noted Berenberg analyst Holger Schmieding.

Early corporate news in London featured a host of M&A action, with Ladbrokes Coral-owner Entain confirming it has received a takeover proposal from US partner MGM Resorts International, while Ferguson said it has struck a deal to sell its UK heating and plumbing business Wolseley UK for a net GBP308 million. Media firm S4 Capital meanwhile, kicked off 2021 with two acquisitions.

Ladbrokes Coral-owner Entain jumped 27% early Monday to 1,440.50 pence, giving it a market capitalisation of GBP8.47 billion.

The Wall Street Journal on Sunday, citing sources familiar with the matter, had said MGM was looking to buy Entain. The WSJ had said the value of the bid would be above GBP12.85 per share. Entain shares closed New Year's Eve trading at 1,132.50 pence.

Entain said on Monday: "Under the terms of its most recent proposal, MGMRI would offer 0.6 MGMRI shares for each Entain share. Based on closing prices on 31 December 2020, being the last trading day prior to this announcement, MGMRI's proposal represents a value of 1,383 pence per Entain share and a premium of 22% to Entain's share price."

The company said Entain shareholders would own just shy of 42% of the enlarged company under the terms of the offer.

Entain, however, said it told MGM the bid "significantly undervalues the company and its prospects".

"Entain shareholders are encouraged to take no action," the company added. MGM has until February 1 to make a firm offer or walk away.

The news comes after London-listed peers of Entain have received interest from the US or have moved to boost their exposure in the lucrative gambling market there.

Back in September, William Hill agreed to a GBP2.9 billion takeover by US casino and resort operator Caesars Entertainment. And in December, Paddy Power owner Flutter Entertainment struck a USD4.18 billion deal to own nearly all of the US FanDuel gaming business.

In other M&A news, Ferguson climbed 0.3%. It has sold Wolseley UK to private equity firm Clayton, Dubilier & Rice for GBP308 million.

In the financial year that ended July 31, the unit generated revenue of USD1.88 billion. The sale means Ferguson can "focus entirely" on its North American business, noted Chief Executive Kevin Murphy.

"The board's current intention is to make a return of substantially all of the net cash proceeds of sale to shareholders by way of a special dividend," Ferguson added.

Elsewhere in London, S4 Capital said it has bought integrated agency Decoded Advertising and will combine it with its MediaMonks unit. It also has acquired Metric Theory, a digital marketing firm, which will merge with S4's MightyHive.

The news comes after "much of the uncertainty" related to Brexit has been eased, due to the UK agreeing a trade deal with the EU, S4 said.

S4 Capital shares were 2.6% higher.

"The consideration for both Decoded and Metric Theory will be paid, as is usual, half in cash and half by the issue of S4 Capital ordinary shares, with minimum customary lock-ups and no earn-outs, which create fragmentation and hinder a unitary structure," S4 added.

AstraZeneca shares were 1.7% higher on Monday, as first doses of the drugmaker's Covid-19 jab, developed alongside Oxford University, are set to be administered in the UK.

Just over half a million doses of the newly approved vaccine will be available from Monday, with vulnerable groups already identified as the priority for immunisation. Jabs will be delivered at some 730 vaccination sites already established across the UK, with others opening this week to take the total to more than 1,000, according to the Department of Health & Social Care.

In addition, Astra on Monday said it has completed the commercial divestment of heart drugs Atacand and Atacand Plus in over 70 nations to Cheplapharm.

Astra received USD250 million from the German pharmaceutical firm and will receive a further USD150 million in the first half of 2021.

Monday's economic calendar has a raft of manufacturing PMIs, including data from the UK at 0930 GMT, the EU at 0900 GMT before the US at 1445 GMT.

The pound was quoted at USD1.3680 on Monday morning in London, improved from USD1.3656 at the early London equities close on Thursday. The euro was largely unchanged at USD1.2272.

Against the yen, the dollar was trading at JPY102.87, down from JPY103.06 at the London stock market close on Thursday.

Brent oil was quoted at USD53.00 a barrel, ahead of an OPEC meeting on Monday. A barrel of the North Sea benchmark was quoted USD51.10 at the London equities close Thursday.

An ounce of gold fetched USD1,928.91 on Monday morning, up sharply from USD1,894.00 at the London equities close on Thursday.

"Gold prices have started to rise once again as traders are concerned about the possibility of further lockdowns. British Prime Minister Boris Johnson could be announcing tougher lockdown measures this week," said Avatrade analyst Naeem Aslam.

Gold miners Polymetal International and Fresnillo were among the best FTSE 100 performers early on Monday, up 5.4% and 5.8%.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.